Applied Therapeutics Inc. (APLT)
NASDAQ: APLT
· Real-Time Price · USD
0.70
0.10 (15.72%)
At close: Oct 01, 2025, 1:47 PM
15.72% (1D)
Bid | 0.66 |
Market Cap | 100.64M |
Revenue (ttm) | 122K |
Net Income (ttm) | -67.74M |
EPS (ttm) | -0.22 |
PE Ratio (ttm) | -3.18 |
Forward PE | -1.18 |
Analyst | Hold |
Dividends | n/a |
Ask | 0.86 |
Volume | 29,785,247 |
Avg. Volume (20D) | 3,642,428 |
Open | 0.59 |
Previous Close | 0.60 |
Day's Range | 0.58 - 0.90 |
52-Week Range | 0.29 - 10.62 |
Beta | 2.06 |
Ex-Dividend Date | n/a |
About APLT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APLT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for APLT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsApplied Therapeutics Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
-13.72%
Applied Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
10 months ago
-13.79%
Applied Therapeutics shares are trading lower after UBS downgraded the stock from Buy to Neutral and cut its price target from $13 to $2.